Publication details

Structure-guided discovery of cyclin-dependent kinase inhibitors

Authors

FISCHMANN Thierry HRUZA Alan DUCA Jose RAMANATHAN Lata MAYHOOD Todd WINDSOR William LE Hung GUZI Timothy DWYER Michael PARUCH Kamil DOLL Ronald LEES Emma PARRY David SEGHEZZI Wolfgang MADISON Vincent

Year of publication 2008
Type Article in Periodical
Magazine / Source Biopolymers
MU Faculty or unit

Faculty of Science

Citation
Field Organic chemistry
Keywords CDK2; kinase; inhibitor
Description CDK2 inhibitors containing the related bicyclic heterocycles pyrazolopyrimidines and imidazopyrazines were discovered through high-throughput screening. Crystal structures of inhibitors with these bicyclic cores and two more related ones show that all but one have a common binding mode featuring two hydrogen bonds (H-bonds) to the backbone of the kinase hinge region. Even though ab initio computations indicated that the imidazopyrazine core would bind more tightly to the hinge, pyrazolopyrimidines gain an advantage in potency through participation of N4 in an H-bond network involving two catalytic residues and bridging water molecules. Further insight into inhibitor/CDK2 interactions was gained from analysis of additional crystal structures. Significant gains in potency were obtained by optimizing the fit of hydrophobic substituents to the gatekeeper region of the ATP binding site. The most potent inhibitors have good selectivity.

You are running an old browser version. We recommend updating your browser to its latest version.

More info